{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:57:34Z","timestamp":1779379054637,"version":"3.53.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,4]]},"DOI":"10.7759\/cureus.68663","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T18:55:46Z","timestamp":1725476146000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case Report on Aplasia Cutis Congenita: Insights Into the Impact of Maternal Carbimazole Use"],"prefix":"10.7759","author":[{"given":"Hajar","family":"Elmoqaddem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anass","family":"Ayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Amrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Aplasia cutis congenita","author":"Brackenrich J","year":"2023","unstructured":"Brackenrich J, Brown A. Aplasia cutis congenita. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(86)70082-0","article-title":"Aplasia cutis congenita: a clinical review and proposal for classification","volume":"14","author":"Frieden IJ","year":"1986","unstructured":"Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. 1986, 14:646-60. 10.1016\/s0190-9622(86)70082-0","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/sni.sni_188_17","article-title":"Aplasia cutis congenita: two case reports and discussion of the literature","volume":"8","author":"Blionas A","year":"2017","unstructured":"Blionas A, Giakoumettis D, Antoniades E, et al.. Aplasia cutis congenita: two case reports and discussion of the literature. Surg Neurol Int. 2017, 8:273. 10.4103\/sni.sni_188_17","journal-title":"Surg Neurol Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.anplas.2016.07.003","article-title":"Aplasia cutis congenita: Update and management [Article in French]","volume":"61","author":"Belkhou A","year":"2016","unstructured":"Belkhou A, Fran\u00e7ois C, Bennis Y, Duquennoy-Martinot V, Guerreschi P. Aplasia cutis congenita: Update and management [Article in French]. Ann Chir Plast Esthet. 2016, 61:450-61. 10.1016\/j.anplas.2016.07.003","journal-title":"Ann Chir Plast Esthet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2016.02.018","article-title":"Aplasia cutis congenita and antithyroid drugs during pregnancy: case series and literature review [Article in French]","volume":"143","author":"Sachs C","year":"2016","unstructured":"Sachs C, Tebacher-Alt M, Mark M, Cribier B, Lipsker D. Aplasia cutis congenita and antithyroid drugs during pregnancy: case series and literature review [Article in French]. Ann Dermatol Venereol. 2016, 143:423-35. 10.1016\/j.annder.2016.02.018","journal-title":"Ann Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420320221","article-title":"Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy","volume":"32","author":"Milham S Jr","year":"1985","unstructured":"Milham S Jr. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy. Teratology. 1985, 32:321. 10.1002\/tera.1420320221","journal-title":"Teratology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1096","article-title":"Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil","volume":"65","author":"Diav-Citrin O","year":"2002","unstructured":"Diav-Citrin O, Ornoy A. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology. 2002, 65:38-44. 10.1002\/tera.1096","journal-title":"Teratology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0135","article-title":"Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?","volume":"171","author":"Laurberg P","year":"2014","unstructured":"Laurberg P, Andersen SL. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?. Eur J Endocrinol. 2014, 171:R13-20. 10.1530\/EJE-14-0135","journal-title":"Eur J Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2010.07.001","article-title":"Birth defects observed with maternal carbimazole treatment: six cases reported to Nice's Pharmacovigilance Center","volume":"71","author":"Koenig D","year":"2010","unstructured":"Koenig D, Spreux A, Hi\u00e9ronimus S, Chichmanian RM, Bastiani F, F\u00e9nichel P, Brucker-Davis F. Birth defects observed with maternal carbimazole treatment: six cases reported to Nice's Pharmacovigilance Center. Ann Endocrinol (Paris). 2010, 71:535-42. 10.1016\/j.ando.2010.07.001","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/132041","article-title":"Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use","volume":"2009","author":"Rivkees SA","year":"2009","unstructured":"Rivkees SA, Mattison DR. Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol. 2009, 2009:132041. 10.1155\/2009\/132041","journal-title":"Int J Pediatr Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2014.07.010","article-title":"Pregnancy and thyroid disorders [Article in French]","volume":"36","author":"Bricaire L","year":"2015","unstructured":"Bricaire L, Groussin L. Pregnancy and thyroid disorders [Article in French]. Rev Med Interne. 2015, 36:203-10. 10.1016\/j.revmed.2014.07.010","journal-title":"Rev Med Interne"},{"key":"ref12","article-title":"Aplasia cutis congenita","volume":"192","author":"De Wilde R","year":"1988","unstructured":"De Wilde R, Hesseling M, Petrik R\r\n\r\n. Aplasia cutis congenita. Zeitschrift fu\u0308r Geburtshilfe und Perinatologie. 1988, 192:282-3.","journal-title":"Zeitschrift fu\u0308r Geburtshilfe und Perinatologie"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/284385-a-case-report-on-aplasia-cutis-congenita-insights-into-the-impact-of-maternal-carbimazole-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T18:55:51Z","timestamp":1725476151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/284385-a-case-report-on-aplasia-cutis-congenita-insights-into-the-impact-of-maternal-carbimazole-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.68663","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}